Guru Ownership Trend
Guru Analysis for ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (ACAD), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $144.32 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $52.24 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 127.2%. Conversely, Joel Greenblatt reduced exposure by 57.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for ACADIA Pharmaceuticals Inc. (ACAD)
Major holders include Steven Cohen ($90.21 M), Renaissance Technologies (RenTech) ($40.94 M), Ken Fisher ($17.76 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 6.48 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $52.24 M, with 4 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited ACAD. The total reported sell value was $1.76 M.
Yes, 0 managers opened new positions in ACAD, and 4 increased their existing holdings. The total reported buy value was $54 M.
